Journal profile · Toxicology

Drug and Chemical Toxicology

ISSN 0148-0545 · eISSN 1525-6014 · Informa Healthcare · UNITED STATES · Quarterly · Founded 1977

Drug and Chemical Toxicology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.26; subscription journal; median 119 days to acceptance (99 articles, last 24 months); community-reported acceptance: about 75%; 104 articles in 2025; indexed in SCIE and Scopus.

Impact factor2.26Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review time119 daysMedian, submission to acceptance · 99 articles, last 24 months · Crossref
APC—No source gives fee information
Acceptanceabout 75%Community average
Articles per year1042025 · OpenAlex count

Scope

Aims, scope and focus

Drug and Chemical Toxicology is published by Informa Healthcare and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Carcinogens and Genotoxicity Assessment, Pesticide Exposure and Toxicity and Drug-Induced Hepatotoxicity and Protection, together about 30.7% of its articles. Its main subfields are Health, Toxicology and Mutagenesis. (generated from OpenAlex topic counts and CAS ranking data)

Drug and Chemical Toxicology publishes full-length research papers, review articles and short communications that encompass a broad spectrum of toxicological data surrounding risk assessment and harmful exposure. Manuscripts are considered according to their relevance to the journal. Topics include both descriptive and mechanics research that illustrates the risk assessment implications of exposure to toxic agents. Examples of suitable topics include toxicological studies, which are structural examinations on the effects of dose, metabolism, and statistical or mechanism-based approaches to risk assessment. New findings and methods, along with safety evaluations, are also acceptable. Special issues may be reserved to publish symposium summaries, reviews in toxicology, and overviews of the practical interpretation and application of toxicological data.

Source: LetPub

Research area (LetPub): Toxicology

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology13.8%
  2. Pesticide Exposure and ToxicityAgricultural and Biological Sciences9.3%
  3. Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics7.7%
  4. Effects and risks of endocrine disrupting chemicalsEnvironmental Science7.4%
  5. Environmental Toxicology and EcotoxicologyEnvironmental Science5.8%
  6. Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics5.7%
  7. Heavy Metal Exposure and ToxicityEnvironmental Science5.1%
  8. Drug Transport and Resistance MechanismsMedicine4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorChemistry, MultidisciplinaryZone 3
MinorPharmacology & PharmacyZone 4
MinorToxicologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorChemistry, MultidisciplinaryZone 3
MinorPharmacology & PharmacyZone 4
MinorToxicologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorChemistry, MultidisciplinaryZone 3
MinorPharmacology & PharmacyZone 4
MinorToxicologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
2.26LetPub ·
CiteScore 2026-06
6.6LetPub ·
SJR 2026-06
0.54LetPub ·
SNIP 2026-06
0.76LetPub ·
h-index
38LetPub ·
h-index
68OpenAlex ·
i10-index
1,355OpenAlex ·
2-year mean citedness
2.65OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
2.01%LetPub ·

Volume

Articles per year
104LetPub ·

Articles by year OpenAlex count · 2,667 in total · the current year is incomplete

YearArticlesOpen accessCitations
202684537
202510411204
202413319610
20236510441
202211017947
2021143161,667

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Review time from article dates manuscript dates registered with Crossref · to

119 daysMedian, submission to acceptance · P25–P75 89 days – 164 days

Acceptance to online
median 15 days (99 articles)
Submission to online
median 145 days
Sample
99 articles with submission and acceptance dates (226 in the window); the latest was accepted on

Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".

Other sources

Average review time (community reports)
about 3 monthsLetPub ·
Average acceptance (community reports)
75%LetPub ·

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Subscription journalLetPub

A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.

No source has fee information yet; check the journal's website.

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Informa Healthcare
Country or region
UNITED STATES
Language
English
Frequency
Quarterly
Founded
1977
ISSN
0148-0545
Electronic ISSN
1525-6014
Official links

FAQ

Frequently asked questions about Drug and Chemical Toxicology

What CAS zone is Drug and Chemical Toxicology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Drug and Chemical Toxicology is in Zone 4 of Medicine, and in Zone 3 of the minor category Chemistry, Multidisciplinary / Pharmacology & Pharmacy / Toxicology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Drug and Chemical Toxicology?

The latest impact factor listed by LetPub is 2.26; CiteScore 6.6, h-index 68.

How long does peer review take at Drug and Chemical Toxicology?

Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 119 days (interquartile range 89–164 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Drug and Chemical Toxicology?

According to LetPub and DOAJ records, Drug and Chemical Toxicology is indexed in SCIE and Scopus.

Is Drug and Chemical Toxicology open access, and what is the APC?

Drug and Chemical Toxicology is a subscription journal. Fee information is not available yet; check the journal's website.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .